ACT CAPITAL MANAGEMENT, LLC – Inhibikase Therapeutics, Inc. Transaction History
ACT CAPITAL MANAGEMENT, LLC portfolio value:
$853,000
portfolio value
ACT CAPITAL MANAGEMENT, LLC quarter portfolio value change:
+22.54%
quarter
Inhibikase Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 157K | $0.91 | 937.5K | |
| Q2 2022 | share | Decrease | -12.91% | -139K shares | -897K | $0.74 | 937.5K |
| Q1 2022 | share | 0.00% | 0 shares | 11K | $1.48 | 1.07M | |
| Q4 2021 | share | Increase | +6.58% | 66.5K shares | -337K | $1.5 | 1.07M |
| Q3 2021 | share | Increase | +15.43% | 135K shares | -531K | $1.9 | 1.01M |
| Q2 2021 | share | Increase | 0.00% | 875K shares | 2.45M | $2.8 | 875K |